Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Ulrich Petry

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 2, 2014
HPV and cervical cancerKarl Ulrich Petry
Gynecologic Oncology|October 24, 2012
Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Sarah Scherbring
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 2017
A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in GermanyKarl Ulrich Petry, Cordula Barth, Jürgen Wasem, et al.
Journal of Women'S Health (2002)|May 8, 2004
Using imiquimod for genital warts in female patientsJ Thomas Cox, Karl-Ulrich Petry, Eva Rylander, et al.
Gynecologic Oncology|August 28, 2014
Laser-skinning colpectomy for extended vaginal intraepithelial neoplasia and microinvasive cancerAlexander Luyten, Hana Hastor, Teodora Vasileva, et al.
Papillomavirus Research (Amsterdam, Netherlands)|November 29, 2017
Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancersKarl Ulrich Petry, Clemens Liebrich, Alexander Luyten, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 2, 2016
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in GermanyNathalie Largeron, Karl Ulrich Petry, Jorge Jacob, et al.
British Journal of Cancer|April 17, 2019
Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, GermanyJohannes Horn, Agnieszka Denecke, Alexander Luyten, et al.
BMC Infectious Diseases|December 25, 2012
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
Journal of Medical Virology|February 19, 2010
Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 testBetti Schopp, Barbara Holz, Manola Zago, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 2, 2014
HPV and cervical cancerKarl Ulrich Petry
Gynecologic Oncology|October 24, 2012
Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Sarah Scherbring
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 2017
A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in GermanyKarl Ulrich Petry, Cordula Barth, Jürgen Wasem, et al.
Journal of Women'S Health (2002)|May 8, 2004
Using imiquimod for genital warts in female patientsJ Thomas Cox, Karl-Ulrich Petry, Eva Rylander, et al.
Gynecologic Oncology|August 28, 2014
Laser-skinning colpectomy for extended vaginal intraepithelial neoplasia and microinvasive cancerAlexander Luyten, Hana Hastor, Teodora Vasileva, et al.
Papillomavirus Research (Amsterdam, Netherlands)|November 29, 2017
Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancersKarl Ulrich Petry, Clemens Liebrich, Alexander Luyten, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 2, 2016
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in GermanyNathalie Largeron, Karl Ulrich Petry, Jorge Jacob, et al.
British Journal of Cancer|April 17, 2019
Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, GermanyJohannes Horn, Agnieszka Denecke, Alexander Luyten, et al.
BMC Infectious Diseases|December 25, 2012
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
Journal of Medical Virology|February 19, 2010
Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 testBetti Schopp, Barbara Holz, Manola Zago, et al.
Pageof 5